Figures & data
Table 1 Baseline demographics and medical history of studied patients
Table 2 Clinical outcomes and cerebral blood flow indices measured during 90-day follow-up
Table 3 Comparison of outcomes measured during 90-day follow-up between the age subgroups among cerebrolysin-treated patients